KOL Relationship Summit

This two day event will help pharmaceutical, biotechnology and medical device companies, whether large or small, establish a reliable method of identifying, mapping, recruiting, interacting, and communicating with both global and local KOLs and thought leaders, understand the tools needed to help drive the success of a specific drug or medical device through KOLs, balance compliance with business objectives, and learn how to increase interactions and disclosures with KOLs and other thought leaders. Other topics include an update of the Physician Sunshine Act and how it affects KOL activities, determining Fair Market Value (FMV) and a proper reporting system, how to partner with the correct people through a successful marketing and sales campaign, and the use and interaction of social media in expanding your networking market and KOL identification. We look forward to greeting you in August!

FEATURED SESSIONS INCLUDE

KOL Identification
Profiling and Identifying Value Added KOLs
Marc Jensen, National Director, Pulmonary/Cardiology
MSL, BAYER HEALTHCARE PHARMACEUTICALS

Case Study
How Independently Based Data Determination Allows for Better KOL Interaction and Disclosure
Jonas Hylton, PharmD, RPh, BS, Medical & Scientific
Affairs, CEPHALON ONCOLOGY